HexafluOride, a Contrast Agent for Placenta Echo-angiography
Condition(s):PregnancyLast Updated:December 6, 2019Completed
Hide Studies Not Open or Pending
Condition(s):PregnancyLast Updated:December 6, 2019Completed
Condition(s):Pregnant WomenLast Updated:October 4, 2021Completed
Condition(s):PregnancyLast Updated:September 22, 2022Withdrawn
Condition(s):Pregnancy ComplicationLast Updated:April 5, 2016Completed
Condition(s):Placenta AccretaLast Updated:December 6, 2016Completed
Condition(s):Placenta PreviaLast Updated:November 17, 2017Completed
Condition(s):Pregnancy; Obesity; PreeclampsiaLast Updated:May 12, 2022Completed
Condition(s):IUGRLast Updated:July 4, 2006Unknown status
Condition(s):Pre-eclampsia; Intra-uterine Growth Restriction; Placental Insufficiency; 3D Doppler UltrasoundLast Updated:December 16, 2020Completed
Condition(s):Placenta; ImplantationLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.